Stockreport

Correvio Announces Outcome Of FDA Advisory Committee Meeting Reviewing Brinavess™ For The Treatment Of Recent Onset Atrial Fibrillation

CORREVIO PHARMA CORP ORDINARY SHARES  (CORV) 
Last correvio pharma corp ordinary shares earnings: 11/14 07:00 am Check Earnings Report
PDF NASDAQ: CORV    TSX: CORV VANCOUVER, Dec. 10, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commer [Read more]